Transgene Biotek Clarifies Non-Applicability of Regulation 32(1) for Q2 FY27
Transgene Biotek Ltd 路 Others (Uncategorized) 路 04 Oct 2026, 12:08 am
Transgene Biotek Clarifies Non-Applicability of Regulation 32(1) for Q2 FY27 Transgene Biotek informed the BSE that Regulation 32(1) of SEBI LODR Regulations regarding the Statement of Deviation or Variation is not applicable for the quarter ended 30th Sep'26. The company confirmed that no funds were raised through public, rights, preferential issues, or QIPs during the reporting period, rendering deviation disclosures inapplicable. Furthermore, the company noted its inability to submit via XBRL mode due to system restrictions on NIL entries.
Original exchange filing (PDF)
More announcements from Transgene Biotek Ltd
- CUT OFF DATE 路 13 Nov 2026
- Unaudited Financial Results 路 13 Nov 2026
- 1) Unaudited Financial Results: Considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended 30th September, .... 路 13 Nov 2026
- Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve To consider and approve the .... 路 13 Nov 2026
- 1. RESIGNATION OF M/S. HARISH GUMMADI & CO., CHARTERED ACCOUNTANTS: The Board took note of the resignation letter dated 03rd November, 2026, submitted by M/s. Harish Gummadi & Co., Chartered .... 路 04 Nov 2026
- Intimation of Resignation of Statutory of Auditors - M/S. Harish Gummadi & Co.., Chartered Accountants. 路 04 Nov 2026
- 1. APPOINTMENT OF STATUTORY AUDITORS TO FILL THE CASUAL VACANCY: The Board of Directors, based on the recommendation of the Audit Committee, has approved the appointment of M/s. Harish .... 路 02 Nov 2026
- Submission of Additional Details Pursuant to BSE Observation -Resignation of Statutory Auditors under Regulation 30 of SEBI (LODR) Regulations, 2015. 路 01 Nov 2026
